Anti-Human CD142/F3/TF Antibody (SAA2335) from ProteoGenix; catalogue ARO-A22724; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CD142/F3/TF Antibody (SAA2335) is a highly specific and sensitive antibody designed for the detection of CD142/F3/TF protein in human samples. CD142, also known as Tissue Factor (TF), is a transmembrane glycoprotein that plays a crucial role in the initiation of blood coagulation. It is expressed on the surface of various cell types, including endothelial cells, monocytes, and macrophages.
This antibody binds to the extracellular domain of CD142 and can be used for both research and diagnostic purposes. It has been extensively tested and validated for its specificity and sensitivity, making it a reliable tool for studying the function and expression of CD142 in different biological systems.
The Anti-Human CD142/F3/TF Antibody (SAA2335) has a wide range of applications in the field of biotechnology. It can be used for immunohistochemistry (IHC), flow cytometry, and Western blotting techniques. Its high sensitivity and specificity make it an ideal choice for detecting CD142 in various human tissues and cell lines.
This antibody has been successfully used in various experimental settings to study the role of CD142 in different biological processes. In one study, it was used to investigate the expression of CD142 in human breast cancer tissues, revealing its potential as a biomarker for cancer progression. In another study, it was used to examine the effect of inflammatory cytokines on the expression of CD142 in human endothelial cells, providing insights into the regulation of blood coagulation.
In addition, this antibody has been used in preclinical studies to evaluate the efficacy of potential anti-coagulant therapies. Its ability to specifically target CD142 makes it a valuable tool for identifying potential drug targets and evaluating their effectiveness.
In summary, the Anti-Human CD142/F3/TF Antibody (SAA2335) is a highly specific and sensitive tool for studying the function and expression of CD142 in human samples. Its applications in various techniques and its successful use in experimental studies make it a valuable addition to any biotech laboratory. Order now and unlock the potential of CD142 research in your studies.
ProteoGenix catalogue number ARO-A22724. For research use only.
Target: Tissue factor, TF, Coagulation factor III, Thromboplastin, CD142, F3; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
